Delivery Order SPE2DX22D0010-SPE2D826FAV14
Award Date 11/4/25
Potential Completion Date 11/5/25
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,658.76 to AmerisourceBergen Drug Corp for the supply of Vyvanse capsules (30 mg) on August 20, 2025. This firm fixed-price delivery order, which is expected to be completed by August 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no set-aside designation, leveraging...
- The Department of Defense's Medical Supply Chain awarded a $26,751.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Vyvanse capsules (50mg) on October 3, 2025, with an ultimate completion date of October 6, 2025. This non-compete, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order valued at $4,459.00 to AmerisourceBergen Drug Corp for the supply of Vyvanse 20 mg capsules (100-count units). This competitively awarded, non-set-aside contract employs firm fixed pricing and carries an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is fulfilling this order from its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $17,194.58 to AmerisourceBergen Drug Corp for the supply of Vyvanse 20 mg capsules (100-count units) under a firm fixed price contract. The order, awarded on September 26, 2025, with an ultimate completion date of September 29, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is fulfilling this requirement through its corporate office and will perform all...
- The Defense Logistics Agency's Medical Supply Chain awarded a $17,094.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Vyvanse capsules 50mg, with completion targeted for September 15, 2025. This non-set-aside delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's existing contract vehicle and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for 100 capsules of Vyvanse 30 mg at a ceiling value of $3,913.63. This is a firm fixed-price delivery order with an ultimate completion date of September 26, 2025, executed under a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $13,562.15 to AmerisourceBergen Drug Corp for Vyvanse 50mg capsules. This firm fixed-price contract, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a competitively awarded non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $10,360.56 to AmerisourceBergen Drug Corp for the supply of Vyvanse 40 mg capsules (100-count units) under a firm fixed-price contract. The order, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. This delivery order is a non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $16,827.85 for Vyvanse capsules 70mg on June 16, 2025, with completion expected by June 17, 2025. The contract utilizes firm fixed-price pricing and carries no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vyvanse 20 mg capsules (100-count units) under a firm fixed-price contract valued at $1,783.60. The order was competitively awarded without set-aside designation and carries an ultimate completion date of October 22, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from its corporate office location in the same...